发明名称 |
THERAPEUTIC FOR TREATING CLOSTRIDIUM DIFFICILE INFECTION |
摘要 |
The invention relates to deoxyribonuclease for use in the treatment of a suspected or existing C. difficile infection; a pharmaceutical or veterinary composition or formulation comprising at least deoxyribonuclease for use in the treatment of a suspected or existing C. difficile infection; a combination therapeutic comprising at least deoxyribonuclease for use in the treatment of a suspected or existing C. difficile infection; a method of treating a mammal suspected of being infected with, or infected with, C. difficile comprising the use of at least deoxyribonuclease; a method of cleaning or sterilising a material or product comprising the use of at least deoxyribonuclease; and a cleaning or sterilising product impregnated with or containing at least deoxyribonuclease. |
申请公布号 |
US2016058846(A1) |
申请公布日期 |
2016.03.03 |
申请号 |
US201514932669 |
申请日期 |
2015.11.04 |
申请人 |
London School of Hygiene and Tropical Medicine |
发明人 |
Dawson Lisa;Wren Brendan |
分类号 |
A61K38/46;C11D3/48;A61L2/16;C11D3/386;A61K45/06;A61K38/48 |
主分类号 |
A61K38/46 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating a mammal suffering from a Clostridium difficile infection comprising administering to said mammal an effective amount of a deoxyribonuclease or a functional fragment thereof, thereby treating the Clostridium difficile infection. |
地址 |
London GB |